Randomized, Placebo-controlled, Double-blinded Study of Single Immediate Instillation of EO9 After TURBT in Patients With NMIBC.
Phase of Trial: Phase II/III
Latest Information Update: 01 Apr 2017
At a glance
- Drugs Apaziquone (Primary) ; Apaziquone (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 01 Apr 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 06 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 23 Nov 2011 New trial record